Michal Nath Puri's most recent trade in NovoCure Ltd was a trade of 833 Ordinary Shares done at an average price of $15.1 . Disclosure was reported to the exchange on June 30, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 15.13 per share. | 30 Jun 2025 | 833 | 164,514 (0%) | 0% | 15.1 | 12,603 | Ordinary Shares |
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 163,681 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 19.92 per share. | 27 Feb 2025 | 1,162 | 108,931 (0%) | 0% | 19.9 | 23,149 | Ordinary Shares |
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 20.55 per share. | 27 Feb 2025 | 225 | 108,706 (0%) | 0% | 20.6 | 4,624 | Ordinary Shares |
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 15.79 per share. | 31 Oct 2024 | 810 | 110,093 (0%) | 0% | 15.8 | 12,792 | Ordinary Shares |
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 12.24 per share. | 28 Jun 2024 | 1,736 | 110,903 (0%) | 0% | 12.2 | 21,249 | Ordinary Shares |
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 109,443 | 109,443 | - | - | Stock Options (Right to buy) | |
NovoCure Ltd | Nath Michal Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 16.30 per share. | 27 Feb 2024 | 71,574 | 109,167 (0%) | 0% | 16.3 | 1,166,656 | Ordinary Shares |
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2023 | 57,604 | 57,604 | - | - | Stock Option (Right to Buy) | |
NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2023 | 37,593 | 37,593 (0%) | 0% | 0 | Ordinary Shares |